| Company Name | Symbol | Price | Prev. Close | Volume | 1 Year (%) |
|---|---|---|---|---|---|
| TechCreate Group Ltd. Class A Ordinary Shares | TCGL | 172.84 | 172.84 | 0 | +167.74 (3289.02%) |
| Mega Fortune Company Limited - Ordinary Shares | MGRT | 118.00 | 116.50 | 7,171 | +111.94 (1847.19%) |
| Quince Therapeutics, Inc. - Common Stock | QNCX | 31.73 | 31.73 | 0 | +30.05 (1788.69%) |
| The Bank of New York Mellon Corporation Common Stock | BNY | 153.41 | 152.79 | 2,970,395 | +143.25 (1409.94%) |
| TJGC Group Limited - Class A Ordinary Shares | TJGC | 31.89 | 31.89 | 0 | +29.20 (1087.58%) |
| Moderna, Inc. - Common Stock | MRNA | 223.37 | 231.35 | 8,085,639 | +198.41 (794.91%) |
| agilon health, inc. Common Stock | AGL | 115.66 | 110.30 | 152,539 | +100.60 (667.99%) |
| Adlai Nortye Group Ltd. - American Depositary Shares | ANL | 10.61 | 10.52 | 152,057 | +9.10 (602.65%) |
| Erasca, Inc. - Common Stock | ERAS | 15.66 | 15.78 | 8,533,491 | +13.12 (516.54%) |
| Kodiak Sciences Inc - Common Stock | KOD | 111.19 | 108.25 | 972,266 | +92.32 (489.24%) |
| Forte Biosciences, Inc. - Common Stock | FBRX | 76.99 | 76.99 | 0 | +63.15 (456.29%) |
| Climb Bio, Inc. - Common Stock | CLYM | 10.36 | 10.87 | 667,836 | +8.49 (454.01%) |
| Space Exploration Technologies Corp. - Class A Common Stock | SPCX | 139.11 | 139.94 | 78,515,537 | +113.49 (442.87%) |
| SELLAS Life Sciences Group, Inc. - Common Stock | SLS | 7.860 | 8.030 | 11,201,598 | +6.40 (438.36%) |
| Vince Holding Corp. - Common Stock | VNCE | 13.67 | 12.91 | 190,590 | +10.97 (406.30%) |
| CareDx, Inc. - Common Stock | CDNA | 77.88 | 79.81 | 716,983 | +62.01 (390.74%) |
| MindForge Inc. - Class A Ordinary Shares | MF | 19.50 | 18.90 | 37,998 | +15.28 (362.09%) |
| Spyre Therapeutics, Inc. - Common Stock | SYRE | 104.00 | 102.91 | 746,235 | +81.37 (359.57%) |
| PACS Group, Inc. Common Stock | PACS | 48.32 | 48.00 | 464,466 | +37.62 (351.59%) |
| Galmed Pharmaceuticals Ltd. - Ordinary Shares | GLMD | 4.630 | 4.630 | 0 | +3.56 (332.71%) |
| Avita Medical, Inc. - Common Stock | RCEL | 15.63 | 16.20 | 497,278 | +11.89 (317.91%) |
| MaxLinear, Inc - Common Stock | MXL | 55.78 | 58.96 | 1,696,840 | +42.00 (304.79%) |
| AN2 Therapeutics, Inc. - Common Stock | ANTX | 4.550 | 4.440 | 205,686 | +3.42 (302.65%) |
| Fossil Group | FOSL | 8.430 | 8.740 | 1,127,824 | +6.33 (301.43%) |
| AXT Inc - Common Stock | AXTI | 41.84 | 43.54 | 10,664,845 | +31.40 (300.77%) |
| Oruka Therapeutics, Inc. - Common Stock | ORKA | 105.35 | 104.99 | 679,679 | +78.97 (299.36%) |
| Q32 Bio Inc. - Common Stock | QTTB | 8.710 | 8.820 | 243,851 | +6.50 (294.12%) |
| Anterix Inc. - Common Stock | ATEX | 80.14 | 82.69 | 199,417 | +59.28 (284.18%) |
| Eton Pharmaceuticals, Inc. - Common Stock | ETON | 63.93 | 61.45 | 601,303 | +47.05 (278.73%) |
| Twist Bioscience Corporation - Common Stock | TWST | 111.60 | 114.22 | 2,047,038 | +81.70 (273.24%) |